Literature DB >> 22144259

Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9.

Shilla Mutamba1, Asher Allison, Yashwant Mahida, Paul Barrow, Neil Foster.   

Abstract

We report for the first time that expression of the novel IL-1 cytokine receptor IL-1Rrp2 (IL-1R6) is unique to DCs within the human myelomonocytic lineage. IL-1Rrp2 was expressed by monocyte-derived dendritic cells (MDDCs) which was dose-dependently increased by IL-4 and correlated with increased numbers of differentiated MDDCs. Human plasmacytoid DCs also express IL-1Rrp2 but the receptor is not expressed by either myeloid DC type 1 (mDC1) or mDC2 cells. We also show that IL-1F8 or IL-1F9 cytokines, which signal through IL-1Rrp2, induce maturation of MDDCs, as measured by increased expression of HLA-DR and CD83 and decreased expression of CD1a. Furthermore, IL-1F8 stimulated increased CD40 and CD80 expression and IL-18 and IL-12 p70 production by MDDCs, which induced proliferation of IFN-γ-producing CD3(+) lymphocytes (indicative of inflammatory Th1 subsets). IL-1F8 and IL-1F2 were equipotent in their ability to stimulate IL-18 secretion from MDDCs but IL-1F8 was not as potent as IL-1F2 in stimulating secretion of IL-12p70 from MDDCs or inducing lymphocyte proliferation Therefore, IL-1Rrp2 expression by some DC subsets may have an important function in the human immune response in vivo via its role in differentiation of inflammatory Th1 lymphocytes.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22144259     DOI: 10.1002/eji.201142035

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.

Authors:  Andrew Johnston; Xianying Xing; Liza Wolterink; Drew H Barnes; ZhiQiang Yin; Laura Reingold; J Michelle Kahlenberg; Paul W Harms; Johann E Gudjonsson
Journal:  J Allergy Clin Immunol       Date:  2016-12-31       Impact factor: 10.793

2.  Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

Authors:  James DeVoti; Lynda Hatam; Alexandra Lucs; Ali Afzal; Allan Abramson; Bettie Steinberg; Vincent Bonagura
Journal:  Mol Med       Date:  2014-08-28       Impact factor: 6.354

Review 3.  Cytokines in psoriasis.

Authors:  Jaymie Baliwag; Drew H Barnes; Andrew Johnston
Journal:  Cytokine       Date:  2015-01-10       Impact factor: 3.861

4.  Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Authors:  Aliyah M Weinstein; Nicolas A Giraldo; Florent Petitprez; Catherine Julie; Laetitia Lacroix; Frédérique Peschaud; Jean-François Emile; Laetitia Marisa; Wolf H Fridman; Walter J Storkus; Catherine Sautès-Fridman
Journal:  Cancer Immunol Immunother       Date:  2018-10-12       Impact factor: 6.968

Review 5.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

6.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

7.  IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.

Authors:  Xuefeng Wang; Xin Zhao; Chao Feng; Aliyah Weinstein; Rui Xia; Wen Wen; Quansheng Lv; Shuting Zuo; Peijun Tang; Xi Yang; Xiaojuan Chen; Hongrui Wang; Shayang Zang; Lindsay Stollings; Timothy L Denning; Jingting Jiang; Jie Fan; Guangbo Zhang; Xueguang Zhang; Yibei Zhu; Walter Storkus; Binfeng Lu
Journal:  Cancer Cell       Date:  2015-08-27       Impact factor: 31.743

Review 8.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

9.  IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.

Authors:  Alexander M Foster; Jaymie Baliwag; Cynthia S Chen; Andrew M Guzman; Stefan W Stoll; Johann E Gudjonsson; Nicole L Ward; Andrew Johnston
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422

Review 10.  Interleukin-36: Structure, Signaling and Function.

Authors:  Li Zhou; Viktor Todorovic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.